Shree Pacetronix Ltd
Shree Pacetronix Ltd Live Price Chart
Performance
| Previous Close | ₹ 108.6 |
| High | ₹ 120 |
| Volume | 549 |
| 52W Range | ₹ 61.11 - ₹ 283.15 |
| Open | ₹ 120 |
| Low | ₹ 111.05 |
| Market Cap | ₹ 93 Cr |
Shree Pacetronix Ltd Technicals
| 20 Day | ₹ 120.983 |
| 50 Day | ₹ 141.663 |
| 100 Day | ₹ 160.493 |
| 200 Day | ₹ 162.112 |
| 20 Day | ₹ 120.070 |
| 50 Day | ₹ 137.275 |
| 100 Day | ₹ 189.657 |
| 200 Day | ₹ 165.777 |
Shree Pacetronix Ltd Fundamentals
| ROCE | 17.452 |
| P/E Ratio | 17.050 |
| P/B Ratio | 2.600 |
| Industry P/E | 2.600 |
| Debt to Equity | 71.897 |
| ROE | 14.703 |
| EPS | 6.840 |
| Dividend Yield | 0.000 |
| Book Value | 44.911 |
| Face Value | 10.000 |
Shree Pacetronix Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 16.9191406 | 22.1763919 | 20.2848857 | 9.0931104 | 7.607592 |
| Total Expenses | 15.8786236 | 17.553581 | 15.6876789 | 8.2081611 | 7.2972774 |
| Profit After Tax | 0.75304 | 3.3583484 | 3.2476033 | 0.6520979 | 0.1835281 |
Shree Pacetronix Ltd Shareholding Pattern
| Promoter Holdings | 25.800 % |
| FIIs | 0.136 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 45.911 % |
| Others - | 28.153 % |
About Shree Pacetronix Ltd
Shree Pacetronix Limited, a leading manufacturer / exporter of Pacemakers, was incorporated in January 1988 as a Private Limited Company and converted into a Public Limited Company in 1993. It has a plant at Pithampur, Madhya Pradesh with installed capacity to produce 4800 pacemakers per annum. Pacemakers are used to treat patients suffering mainly from heart conditions, such as heart failure and arrhythmias. These devices are implanted under patient's chest by cardiologist to deal with various indications and used for the treatment of heart medical conditions. Innovations such as longer-lasting batteries, advanced remote monitoring capabilities, and next-generation leadless and MRI-safe pacemakers are key pillars of the R&D agenda. These developments not only improve clinical outcomes but also align with evolving patient needs and healthcare provider expectations, allowing to maintain a competitive edge in the rapidly advancing pacemaker industry. ...
